British drug companies and regulators said on Thursday they have agreed a new way of working that would speed up clinical trials of new medicines.
The deal, signed by the Association of the British Pharmaceutical Industry (ABPI) and the Department of Health, means that companies will no longer have to start from scratch each time they want approval to start a new trial.
תגובות רוצה להצטרף לדיון?
יש להתחבר כדי להגיב.
התחבראין תגובות עדיין. היה הראשון להגיב!